Navigation Links
Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer

EAST ALTON, Ill., Nov. 30 /PRNewswire/ -- The Simmons law firm's Trent Miracle will serve on a committee dedicated to representing thousands of women that were seriously injured after taking Yaz (Yasmin), the popular birth control pill manufactured and marketed by Bayer Pharmaceuticals.

The U.S. Judicial Panel on Multidistrict Litigation has ordered that all federal Yaz and Yasmin birth control pill lawsuits be consolidated and centralized for pretrial litigation in the Southern District of Illinois under the guidance of U.S. District Judge David R. Herndon in East St. Louis. Miracle is one of 13 attorneys selected to manage the national litigation.

"We anticipate seeing as many as 10,000 cases," said Miracle, who heads up the Simmons firm's pharmaceutical litigation practice. "Unfortunately, the injuries are widespread and serious. Consolidating these lawsuits into multidistrict litigation should allow us to help these women in a manner that's both efficient and fair."

All of the cases involve allegations that the popular birth control pills containing the new progestin drospirenone increase the risk of serious and potentially life-threatening health problems, such as heart attacks, strokes, pulmonary embolisms, deep vein thrombosis, gallbladder disease, and sudden death. The complaints allege that Bayer Pharmaceuticals, which manufactures both Yaz and Yasmin, failed to adequately research their products, fraudulently concealed the risk of injury, negligently failed to warn about the degree of risk women faced, and misrepresented the safety of the drugs in comparison to other available birth control pills.

Miracle said his role on the Steering Committee will be defined in the coming months as he and other attorneys continue to gather evidence against Bayer. Earlier this year Miracle took over the Simmons firm's growing pharmaceutical practice, which already is recognized on the national stage for its groundbreaking litigation of drug and supplement cases against major pharmaceutical companies. Miracle has worked extensively litigating against the development and marketing of dangerous drugs such as Vioxx, Bextra, Ortho Evra, Ephedra and Phenylpropanolamine (PPA), Oxycontin, and others.

"When corporations put profits over safety, the legal system is often the last resort for the people that were hurt," said Miracle. "I look forward to serving on this committee and working hard to represent the interest of thousands of women who were unfairly harmed."

About Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons firm is a leading national law firm in the fight against mesothelioma. With offices in Illinois and California, the firm has represented thousands of patients and families affected by mesothelioma from all across the country. The Simmons firm is passionate about improving the lives of victims of mesothelioma and asbestos-related illnesses and has pledged over $15 million to cancer research. The firm also has practice areas in intellectual property, pharmaceutical litigation, and business litigation.

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
2. New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction
3. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
4. Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients
5. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
6. Study Confirms: Your Hidden Food Allergies Are Making You Fat
7. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
8. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
9. Sosei Confirms the Safety of SD118 in Two Phase I Trials
10. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
11. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Post Your Comments:
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):